Cadrenal Therapeutics, Inc. - Common Stock

Cadrenal Therapeutics, Inc. - Common Stock Share · US1276361086 · CVKD (XNAS) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Cadrenal Therapeutics, Inc. - Common Stock
Analyst Grade Summary
gauge-img
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
1
0
0
0
No Price
01.05.2026 23:00
Current Prices from Cadrenal Therapeutics, Inc. - Common Stock
ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
CVKD
USD
01.05.2026 23:00
6,25 USD
-0,42 USD
-6,30 %
IEXG: IEX
IEX
CVKD
USD
01.05.2026 19:59
6,40 USD
-0,27 USD
-4,05 %
Share Float & Liquidity
Free Float 77,63 %
Shares Float 1,95 M
Shares Outstanding 2,51 M
Company Profile for Cadrenal Therapeutics, Inc. - Common Stock Share
Cadrenal Therapeutics, Inc. operates as a clinical development biopharmaceutical company. The company focuses on developing Tecarfarin, a novel therapy with orphan drug indication for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was incorporated in 2022 and is headquartered in Ponte Vedra, Florida.

Company Data

Name Cadrenal Therapeutics, Inc. - Common Stock
Company Cadrenal Therapeutics, Inc. Common Stock
Symbol CVKD
Website https://www.cadrenal.com
Primary Exchange XNAS NASDAQ
ISIN US1276361086
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Quang X. Pham
Market Capitalization 24 Mio
Country United States of America
Currency USD
Employees 0,0 T
Address 822 A1A North, 32082 Ponte Vedra
IPO Date 2023-01-20

Stock Splits

Date Split
20.08.2024 1:15

Ticker Symbols

Name Symbol
NASDAQ CVKD
More Shares
Investors who hold Cadrenal Therapeutics, Inc. - Common Stock also have the following shares in their portfolio:
GEELY AUTO. HLDGS ADR'S
GEELY AUTO. HLDGS ADR'S Depository Receipt
LANDWIRT.R.BK 26/31LS-MTN
LANDWIRT.R.BK 26/31LS-MTN Bond